Role of HCV coinfection towards disease progression and survival in HIV-1 infected children: A follow-up study of 10 years

Journal of Tropical Pediatrics

Volumn 52, Issue 3, 2006, Pages 206-211

  Onkar Shivraj, Swami ^a   Chattopadhya, Debasish ^b,d   Grover, Gurprit ^a   Kumar, Ashok ^c   Baveja, Usha K ^b  

^a UNIVERSITY OF DELHI   (India)

^b NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; NONHUMAN; RISK ASSESSMENT; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; SUPERINFECTION; SURVIVAL TIME; THALASSEMIA MAJOR;

BLOOD TRANSFUSION; CD4 LYMPHOCYTE COUNT; CHILD; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; INDIA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; SURVIVAL RATE; THALASSEMIA;

EID: 33745713916     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmi103     Document Type: Article

References (23)

1. Chattopadhya D, Aggarwal R, Prakash C, et al. Sexually transmitted disease (STD) markers in multi-transfused children in relation to human immunodeficiency virus type-1 infection-impact of STD markers in blood donors. J Trop Ped 1997;43:178-181.
2. Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and human immune deficiency virus marker in multi-transfused patients. J Trop Pediatr 2001;47:239-242.
3. Eyster ME, Laura S, Diamondstone J-M W, et al. Natural history of hepatitis C virur infection in multi-transfused haemophiliacs: Effect of coinfection with human immunodeficiency virus. J AIDS 1993;6: 602-610.
4. Ockenga J, Tillmann HL, Trautwein C, et al. Hepatitis B and C in HIV-1 infected patients. Prevalence and prognostic value. J Hepatol 1997;27:18-24.
5. Eyster ME, Fried MW, Adrian M, et al. Increasing hepatitis C virus RNA levels in haemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Blood 1994;84:1020-1023.
6. Staples CT, Rimland D, Dudas D. Hepatitis C in HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) cohort study (HAVACS): The effect of coinfection on survival. Clin Infect Dis 1999;29:150-154.
7. Chattopadhya D, Baveja UK, Bose M, et al. Disease progression markers during asymptomatic phase of HIV-1 infected children with unimpaired CD4+ cell vales: Evaluation of repeat CD4+ cell evaluation vs. other immunological parameters. J Trop Pediatr 2002;48:340-347.
8. CDC revised classification systems for Human Immunodeficiency Virus infection in children less than 13 years of age. Morbidity Mortality Weekly Report 1994;43:1-10.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
10. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall. 1984.
11. Resti M, Azzari C, Rossi ME, et al. Hepatitis C antibodies in a long term follow up of beta-thalassemic children with acute and chronic non A, non B hepatitis. Eur J Pediatr 1992;151:573-576.
12. Lesens O, Deshenes M, Steben M, et al. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated an opportunistic infection. J Infect Dis 1999;179:1254-1258.
13. Piroth L, Duong M, Quantin C, et al. Does hepatitis C co-infection accelerate clinical and immunological evolution of HIV-1 infected patients? AIDS 1998;12:381-388.
14. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss cohort study. Lancet 2000;356:1800-1805.
15. Sobue S, Nomura T, Ishikawa T, et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 2001;36:544-551.
16. Artini M, Nisini R, Missale G, et al. Interaction of circulating and liver infiltrating T cell by hepatitis C virus of different subtypes. Viral Immunol 1995;8: 63-73.
17. Khakoo SI, Soni PN, Savage K, et al. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection-correlation with disease activity. Am J Pathol 1997;150:963-970.
18. Horvath J, Raffanti SP. Clinical aspects of interactions between human immunodeficiency virus and hepatotropic viruses. Clin Infect Dis 1994;18:339-347.
19. Soriano V, Gracia-Samaniego J, Brovo R, et al. Morbidity and mortality associated with chronic viral hepatopathy in patients infected with human immunodeficiency virus. Med Clin Bar 1995;104: 641-644.
20. Telfer P, Sabin C, Devereux H, et al. The progression of HCV associated liver disease in cohort of haemophiliac pateints. Br J Haematol 1994;87:555-561.
21. Darby SC, Ewast SW, Giangrande PLE, et al. For the UK Haemophilia Center Director's Organisation. Mortality from liver cancer and liver disease in haemophiliac men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350:1425-1431.
22. Daar ES, Lynn H, Donfield S, et al. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in haemophiliacs. J Infect Dis 2001;183:589-595.
23. Sabin CA, Telfer P, Philips AN, et al. Association between hepatitis C virus genotype and human immunodeficiency virus disease progression in cohort of haemophiliac men. J Infect Dis 1997;175: 164-168.